Market Place
Sourcing Support
VectorBuilder Wins BioIndustrial Innovation of the Year Award
19 Nov 2024 //
BUSINESSWIRE
VectorBuilder’s Dr. Bruce Lahn Named to Forbes China Top 100
14 Nov 2024 //
BUSINESSWIRE
VectorBuilder’s Dr. Bruce Lahn Named To 2024 PharmaVoice 100
16 Oct 2024 //
BUSINESSWIRE
Study Reveals High Error Rates In Lab-Made Plasmids Globally
01 Jul 2024 //
PRESS RELEASE
VectorBuilder Included in Global Unicorn Index by Hurun Research Institute
17 Apr 2024 //
PRESS RELEASE
Build a Better Future with VectorBuilder
10 Apr 2024 //
PRESS RELEASE
Minaris And VectorBuilder Collaborate On Therapeutic Breakthroughs
11 Mar 2024 //
PRESS RELEASE
Stand Up Therapeutics Signed with VectorBuilder for World`s First Gene Therapy
29 Dec 2022 //
PR NEWSWIRE
VectorBuilder bags $57M to build out gene delivery capabilities
25 Oct 2022 //
FIERCEPHARMA
Gene delivery startup VectorBuilder secures CNY410 M in Series C round
19 Oct 2022 //
BIOSPECTRUMASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.